LYPLA2 inhibition alleviates hepatic sinusoidal obstruction syndrome by suppressing pSTAT3-dependent HSP60 transcription
Biochimica et Biophysica Acta: Molecular Basis of Disease
· Elsevier
Аннотация
Publication date: March 2027 Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Volume 1873, Issue 3 Author(s): Xiaofei Ren, Haiwang Zhang, Rutao Hong, Xinyan Du
Читать у издателя →
Цитирование
LYPLA2 inhibition alleviates hepatic sinusoidal obstruction syndrome by suppressing pSTAT3-dependent HSP60 transcription. // Biochimica et Biophysica Acta: Molecular Basis of Disease. – URL: https://www.sciencedirect.com/science/article/pii/S0925443926003911?dgcid=rss_sd_all
LYPLA2 inhibition alleviates hepatic sinusoidal obstruction syndrome by suppressing pSTAT3-dependent HSP60 transcription. Biochimica et Biophysica Acta: Molecular Basis of Disease. https://www.sciencedirect.com/science/article/pii/S0925443926003911?dgcid=rss_sd_all
“LYPLA2 inhibition alleviates hepatic sinusoidal obstruction syndrome by suppressing pSTAT3-dependent HSP60 transcription.” Biochimica et Biophysica Acta: Molecular Basis of Disease.
@article{article37452,
title = {LYPLA2 inhibition alleviates hepatic sinusoidal obstruction syndrome by suppressing pSTAT3-dependent HSP60 transcription},
journal = {Biochimica et Biophysica Acta: Molecular Basis of Disease},
url = {https://www.sciencedirect.com/science/article/pii/S0925443926003911?dgcid=rss_sd_all}
}